Allergy and the skin

Clinical and Experimental Immunology

Volumn 153, Issue SUPPL. 1, 2008, Pages 27-29

  Incorvaia, C ^a,b   Frati, F ^c   Verna, N ^d   D'Alo S ^d   Motolese, A ^e   Pucci, S ^d  

^a ICP Hospital ^*  (Italy)

^b ICP Hospital   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Ospedale Civile   (Italy)

^e OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Atopic dermatitis; Filaggrin; IgE mediated skin disorders; Urticaria

Indexed keywords

ALLERGEN; FILAGGRIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; LYMPHOCYTE ANTIGEN RECEPTOR; OMALIZUMAB; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANGIONEUROTIC EDEMA; ASTHMA; ATOPIC DERMATITIS; CONTACT DERMATITIS; HUMAN; LANGERHANS CELL; MICROORGANISM; PATCH TEST; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; TH2 CELL; URTICARIA;

ALLERGENS; ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INTERMEDIATE FILAMENT PROTEINS; LANGERHANS CELLS; SKIN; TH2 CELLS;

EID: 47649101680     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03718.x     Document Type: Review

References (32)

1. Zuberbier T, Bindslev-Jensen C, Canonica GW et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006 61 : 316 20.
2. Charlesworth EN. Urticaria and angioedema: a clinical spectrum. Ann Allergy Asthma Immunol 1996 76 : 484 96.
3. Greaves MW. Chronic urticaria. J Allergy Clin Immunol 2000 105 : 664 72.
4. Hennino A, Berard F, Guillot J et al. Pathophysiology of urticaria. Clin Rev Allergy Immunol 2006 30 : 3 11.
5. Pastorello EA, Incorvaia C, Ortolani C. The mouth and pharynx. Allergy 1995 50 (Suppl. 20 41 4.
6. Aoki T, Horiko T, Akimoto T. Generalized cold urticaria: detection of heat-sensitive passive transfer substance active at moderate temperature. Clin Exp Dermatol 1982 7 : 377 86.
7. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006 117 : 1415 18.
8. Spector SL, Tan RA. Effects of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007 99 : 190 3.
9. Sands MF, Blume JW, Schwartz SA. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol 2007 120 : 979 81.
10. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004 113 : 651 57.
11. Novak N, Bieber T, Leung DYM. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003 112 : S128 39.
12. Chen L, Martinez O, Overbergh L et al. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 2004 138 : 375 87.
13. Boguniewicz M, Leung DYM. Atopic dermatitis. J Allergy Clin Immunol 2006 117 : S475 80.
14. He R, Oyoshi MK, Jin H, Geha RS. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci USA 2007 104 : 15817 22.
15. Bilsborough J, Leung DY, Maurer M et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006 117 : 418 25.
16. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003 112 : S128 39.
17. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006 38 : 441 6.
18. Cork MJ, Robinson DA, Vasilopoulos Y et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006 118 : 3 21.
19. Ying S, Meng Q, Corrigan CJ, Lee TH. Lack of filaggrin expression in the human bronchial mucosa. J Allergy Clin Immunol 2006 118 : 1386 8.
20. Palmer CN, Ismail T, Lee SP et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol 2007 120 : 64 8.
21. Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007 120 : 150 5.
22. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha R. Epicutaneous sensitization with protein antigens induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigens in mice. J Clin Invest 1998 101 : 1614 22.
23. Fuiano N, Incorvaia C, Prodam F et al. The relationship between the atopy patch test and the clinical expression of the disease in children with atopic eczema/dermatitis syndrome and/or respiratory symptoms. Ann Allergy Asthma Immunol (in press).
24. Kakinuma T, Nakamura K, Wakugawa M et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the diasese activity of atopic dermatitis. Clin Exp Immunol 2002 127 : 270 3.
25. Kagami S, Kakinuma T, Saeki H et al. Significant elevation of serum level of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 2003 134 : 309 13.
26. Leung DY. Infection in atopic dermatitis. Curr Opin Pediatr 2003 15 : 399 404.
27. Sohn MH, Kim CH, Kim WK et al. Effects of staphylococcal enetrotoxin B on specific antibody production in children with atopic dermatitis. Allergy Asthma Proc 2003 24 : 67 71.
28. Breuer K, Haussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of antibacterial treatment in adults with atopic dermatisis. Br J Dermatol 2002 147 : 55 61.
29. Wollenberg A, Wetzel S, Burgdorf WF, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003 112 : 667 74.
30. Howell MD, Wollenberg A, Gallo RL et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006 117 : 836 41.
31. Kollisch G, Kalali BN, Voelcker V et al. Various members of the Toll-like receptors family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005 114 : 531 41.
32. Werfel T, Heeg K, Neumaier M, Renz H. 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004 113 : 565 7.